Ninety One (UK)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-227,339
Closed -$24.4M 329
2016
Q4
$24.4M Buy
227,339
+26,824
+13% +$3.14M 0.13% 142
2016
Q3
$25M Buy
200,515
+3,963
+2% +$468K 0.12% 148
2016
Q2
$20.9M Buy
196,552
+181,849
+1,237% +$21.1M 0.11% 157
2016
Q1
$1.68M Hold
14,703
0.01% 249
2015
Q4
$2.1M Buy
14,703
+720
+5% +$83.1K 0.01% 251
2015
Q3
$1.26M Sell
13,983
-2,481
-15% -$262K 0.01% 252
2015
Q2
$1.9M Sell
16,464
-5,164
-24% -$543K 0.01% 228
2015
Q1
$2.07M Buy
21,628
+219
+1% +$16.4K 0.01% 222
2014
Q4
$1.44M Buy
+21,409
New +$1.33M 0.01% 233

Other funds holding CBPO

Ninety One (UK)'s CBPO Position: Q1 2017 in Review

Ninety One (UK) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 227,339 shares — an estimated $24.4M sold.

Ninety One (UK) first reported a position in CBPO in Q4 2014 and held it in 9 quarters. The position peaked at $25M in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

  • Ninety One (UK) reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
  • Ninety One (UK) sold 227,339 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $24.4M.
  • Ninety One (UK) first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 9 quarters.
  • Ninety One (UK)'s China Biologic Products Holdings, Inc. position peaked at $25M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Ninety One (UK)'s 13F filing for Q1 2017, filed 12 May 2017.